by Mark Curtis | Apr 13, 2015
. Welcome to your deal review for the month of March. Cellular Dynamics threw shareholders for a loop after making a seemingly hasty decision to sell the company off to Fujifilm in a $307* million deal. Merck and synthetic biology specialist Intrexon announced a...
by Mark Curtis | Apr 7, 2015
. Welcome to your Update from the Clinic for the month of March. Investors weren’t so keen on Neuralstem’s topline results in amyotropic lateral sclerosis (ALS). NeoStem’s follow-up data from its PreSERVE study in acute myocardial infarction (AMI) was somewhat...
by Stacey Johnson | Mar 31, 2015
. In May 2012, the Stem Cell Network (SCN) and the Centre for Commercialization of Regenerative Medicine (CCRM) launched Signals Blog, an evolution of SCN’s popular Stem Cell Network Blog and the brainchild of Lisa Willemse, Director of Communications at SCN. Beyond...
by Stacey Johnson | Mar 20, 2015
. American media and telecom billionaire John Malone, along with his horse-breeding wife Leslie, have generously donated U.S. $42.5 million to Colorado State University to launch the CSU Institute for Biologic Translational Therapies to develop regenerative medicine...
by Lisa Willemse | Mar 17, 2015
> Many of us only become acutely aware of our brain when it’s not working quite right. Like, say, if we have a migraine, or are diagnosed with a mental illness. Or we fall on the ice and give ourself a concussion that affects our vision, motor skills and...
by Stacey Johnson | Mar 6, 2015
. The beauty of an infographic (or two) is it speaks for itself. Shared with permission of BioInformant: http://www.bioinformant.com/ Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We...
Comments